Soft Tissue Allografts Market Players:
- Stryker Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ALON SOURCE GROUP
- CONMED Corporation
- LifeSciences Corporation
- Organogenesis Inc.
- RTI Surgical, Inc.
- MIMEDX, Inc.
- Xtant Medical Holdings, Inc.
- Globus Medical, Inc.
- Bone Bank Allografts
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of soft tissue allografts is assessed at USD 5.32 Billion.
The global soft tissue allografts market size was valued at around USD 5.04 Billion in 2025 and is projected to grow at a CAGR of more than 6.2%, reaching USD 9.2 Billion revenue by 2035.
North America’s soft tissue allografts market will hold around 44.2% share by 2035, driven by rising prevalence of arthritis and associated healthcare expenditure.
Key players in the market include Stryker Corporation, ALON SOURCE GROUP, CONMED Corporation, LifeSciences Corporation, Organogenesis Inc., RTI Surgical, Inc., MIMEDX, Inc., Xtant Medical Holdings, Inc., Globus Medical, Inc., Bone Bank Allografts.
